Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Crestor

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The study is one of the priority points of the Russian Scientific Medical Society of Internal Medicine, initiated due to known… Expand
Is this relevant?
2015
2015
The patient is a 75-year-old housewife, who underwent menopause about 20 years ago. She has a long-standing history of back and… Expand
Is this relevant?
2014
2014
The research on patient compliance and efficiency of the use of statins for initial and secondary prevention of cardio-vascular… Expand
Is this relevant?
2012
2012
OBJECTIVE To evaluate the effects of domestic rosuvastatin tablets on coronary plaque in the patients with mild-to-moderate… Expand
Is this relevant?
2010
2010
will also harm sales of other branded products in the antidyslipidaemia market. “The availability of generic atorvastatin will… Expand
  • table 1
  • figure 1
Is this relevant?
2008
2008
actions against seven generics manufacturers — Aurobindo, Apotex, Cobalt, Par, Sandoz, Mylan and Sun — who have submitted… Expand
  • table 1
Is this relevant?
2004
2004
Reason for posting: Rosuvastatin (Crestor) is a relatively new cholesterol-lowering drug that has become one of the top-selling… Expand
Is this relevant?
Review
2004
Review
2004
Rosuvastatin (Crestor) has been recently launched in Belgium by AstraZeneca. This new statin is indicated for the treatment of… Expand
Is this relevant?
2004
2004
If primary endpoint data for cancer treatments aren't met, positive secondary endpoint data will not guarantee approval, says the… Expand
Is this relevant?